SCHEMBL31695347

SCHEMBL31695347

N#Cc1c(-c2ccc(O)c(O)c2)cc(-c2ccc3ccccc3c2)[nH]c1=N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.49
▸ KDR P35968 2/20 0.48
▸ MET P08581 1/20 0.48
▸ PIM1 P11309 8/20 0.48
▸ ALDH1A1 P00352 3/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ BIRC5 O15392 2/20 0.41
▸ IL4 P05112 1/20 0.40
▸ APP P05067 1/20 0.39
▸ PDE9A O76083 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ BCL2L1 Q07817 1/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ MAP2K2 P36507 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31695346 0.88 ATM (0.51) ALOX5KDRMETPIM1ALDH1A1
SCHEMBL31695345 0.86 ATM (0.50) ALOX5KDRMETPIM1ALDH1A1
SCHEMBL31695348 0.84 PIM1 (0.47) ALOX5KDRMETPIM1ALDH1A1
SCHEMBL31695294 0.83 KDR (0.50) KDRMETPIM1ALDH1A1CYP1A2
SCHEMBL31695313 0.81 IL4 (0.54) PIM1ALDH1A1BIRC5IL4ATM
SCHEMBL29335418 0.81 IL4 (0.54) PIM1ALDH1A1BIRC5IL4ATM
SCHEMBL31695323 0.81 MAPT (0.50) KDRMETPIM1ALDH1A1HPGD
SCHEMBL31695357 0.81 IL4 (0.45) PIM1ALDH1A1HPGDHSD17B10BIRC5
SCHEMBL31695290 0.79 MET (0.48) KDRMETPIM1ALDH1A1HPGD
SCHEMBL23841109 0.72 ATM (0.72) KDRMETPIM1BIRC5ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-10-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF IL4, IRAK4, IL5 ALOX5 973/4885KDR 1239/4885MET 1421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback